Recent News Releases
Now approved by Health Canada: Hizentra®
Now approved by Health Canada: Hizentra® (Subcutaneous Immunoglobulin [Human] 20% Liquid) for the Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for maintenance therapy
Lifesaving Medicines Donated For Patients In The Developing World
Ottawa – CSL Behring has shipped more than 10 million international units (IUs) of its medicines to treat hemophilia A to the WFH Global Alliance for Progress (GAP)Program in recognition of World Hemophilia Day.
Press Release Archive
If you are interested in global news from CSL Behring, please visit our Global Press Releases.
CSL Behring News
CSL Sponsors 38th Annual John Molson International
CSL Behring Canada was pleased to sponsor and support the 38th Annual John Molson Int…
Parkville: Past and Present
CSL's original site was once home to its founding director, now it has 2,000 workers.
7 Team Lessons From Dogsledding
Every day takeaways from CSL Behring’s team building adventure in the Rockies.
New Emojis for Scientists
Get ready to text lab coats, petri dishes, test tubes and more.
Rare Disease Day February 28th 2018
Ottawa – CSL Behring Canada staff raise and join their hands in support of patients w…
Scientific Impact: Mentoring Inspires
January is National Mentoring Month, but some seek STEM-focused learning year-round.